trisialoganglioside-gt1 has been researched along with Cranial-Nerve-Diseases* in 2 studies
2 other study(ies) available for trisialoganglioside-gt1 and Cranial-Nerve-Diseases
| Article | Year |
|---|---|
Anti-ganglioside complex antibodies associated with severe disability in GBS.
Ganglioside complexes (GSCs) are known as target antigens in Guillain-Barré syndrome (GBS). To elucidate the clinical importance of the anti-GSC antibodies in GBS, we investigated serum antibodies to GSCs containing two of the gangliosides, GM1, GD1a, GD1b and GT1b, and analyzed clinical features of anti-GSC-positive GBS patients. Thirty-nine (17%) of 234 GBS patients had IgG anti-GSC antibodies. Anti-GSC-positive GBS had antecedent gastrointestinal infection and lower cranial nerve deficits more frequently than control GBS. The presence of antibody specificity to GD1a/GD1b and/or GD1b/GT1b was significantly associated with severe disability and a requirement for mechanical ventilation. Topics: Adult; Autoantibodies; Campylobacter Infections; Campylobacter jejuni; Cranial Nerve Diseases; Disability Evaluation; Electrophysiology; Female; G(M1) Ganglioside; Gangliosides; Gastrointestinal Diseases; Guillain-Barre Syndrome; Humans; Immunoglobulin G; Immunosorbent Techniques; Male; Middle Aged; Respiration, Artificial; Severity of Illness Index | 2007 |
Polyneuritis cranialis related to anti-GT1 a IgG antibody.
Topics: Antibodies, Anti-Idiotypic; Brain Diseases; Cranial Nerve Diseases; Gangliosides; Guillain-Barre Syndrome; Humans; Immunoglobulin G; Male; Middle Aged; Polyneuropathies | 2001 |